1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
  1. 5-HT2A
    Several controversial psychedelic drugs now show promise as powerful therapeutic treatments for depression, anxiety, and PTSD. New data from YouGov suggests that public support for these therapies may have something to do with education level.

    A study by researchers from New York University and Johns Hopkins University showed that a single treatment with psilocybin (the active ingredient in hallucinogenic mushrooms) reduced anxiety and depression in 80% of cancer patients. Another controlled trial showed that on average, after three doses of MDMA, patients experienced a 56% decrease in severity of PTSD symptoms. More importantly, 66% no longer met the criteria for PTSD by the end of the trial. Studies at Yale, Mount Sinai and the National Institute of Mental Health suggest that ketamine relieves depression within six hours, especially in patients who were resistant to conventional antidepressant medicine.

    Despite the stigma surrounding these controlled substances, new data from YouGov shows that many Americans are ready to embrace psychedelic therapies. What’s more, a relationship appears to exist between higher levels of education and increased support for psychedelic research and treatments. At each increasing level of education, there's a corresponding increase in support for medical research into the potential benefits of psychedelic substances, such as psilocybin mushrooms, MDMA, and ketamine. 53% of all respondents support medical research into psychedelic drugs, and this number increases to 69% for respondents with graduate degrees.


    While more than half of all Americans may support research into psychedelics for therapeutic use, a 63% majority also said they would personally be open to medical treatment with psilocybin, ketamine, or MDMA if faced with a pertinent medical condition — assuming the substance is proven safe. The curve of support for all three substances increased with each respondent’s education level. On average, respondents with a post graduate degree were 21 points more likely to try treatment with psilocybin, ketamine, or MDMA than those with a high school diploma or less.


    Original Source

    Written by: Gregory McCarriston, Jun 23, 2017, Majority of Americans ready to embrace psychedelic therapy, YouGov

Recent User Reviews

  1. Phenoxide
    "Psychedelic therapy on the way back.."
    5/5, 5 out of 5, reviewed Jun 26, 2017
    Great to see that big difference between support and oppose, though I doubt many of the general population have researched the topic much.

    I think this certainly suggests that people now see through the 70s/80s propaganda, and are more comfortable with the idea that recreational drugs may also have therapeutic potential. Would be interesting to see the break down of responses by age group.

    Still a long ways to go, but psychedelic research has certainly been on an upward trend these past few years.
    perro-salchicha614 likes this.
  2. Budgetadvisoryservice
    "Once again, great news which is well presented."
    5/5, 5 out of 5, reviewed Jun 25, 2017
    This is great news.

    Where I'm from, pharmaceutical policy is largely driven by policy decisions made in the US. While we are years to decades behind America in making changes to policy around such issues, the clear evidence in this report that Americans overwhelmingly support psychedelic drug supported therapies, especially among those with higher education, tells me that I only need to wait til I'm old, grey and broken to access these therapies legally in my country.

    The American public has a great deal of power when it comes to global drug and health policy. The rising tide of enlightenment indicated in this report is encouraging. I think I should celebrate by taking some therapeutic LSD, coz the Americans said it's okay...
    perro-salchicha614 likes this.


  1. Terpene
    There are some things I simply cannot comprehend. One of them is how anyone could be opposed to the research of a drug or a plant that could help others live happier lives. "I know for a fact that this could not help anybody, and therefore, research should simply not be allowed".

    Really? How closed minded and idiotic does one have to be? It absolutely blows me away. I cannot, for the life of me, understand this mindset. This article helps me realize how much I hate people. Half of them anyways.
To make a comment simply sign up and become a member!